Heart Failure Therapies Privately held medical device company specializing in electrosurgical therapies and new heart failure treatment options, presenting opportunities to enter and expand within the cardiology and interventional electrophysiology spaces.

TELLTALE Launch Recent introduction of the TELLTALE electrosurgical guidewire system with first-in-human procedure, signaling a product with clinical validation and potential for fast market adoption and adjacent procedural uses.

Mid-market Scale Small to mid-size employee base (11-50) indicates agility and potential for rapid collaboration with distributors and hospital-based sales teams; target hospitals and regional centers for pilot programs and case studies.

Revenue Range Current revenue between one and ten million dollars suggests growth opportunities through strategic partnerships, stepwise product line expansion, and value-based selling to larger hospital networks aligned with major competitors.

Digital & Partners Leverages modern tech stack and cloud-based platforms (iCIMS, Microsoft 365, Cloudflare) enabling efficient outreach, candidate and partner onboarding, and digital marketing efforts to accelerate business development and channel partnerships.